Work with Us
University of North Carolina at Chapel Hill: Research to Revenue

University of North Carolina at Chapel Hill

Summit Venture Studio

Research to Revenue Report

Summit Venture Studio (SVS) Opportunities

SVS has identified 15 commercialization opportunities from University of North Carolina at Chapel Hill and scored them based on our proprietary metrics and rubrics.
The SVS model is to identify the top 1% of commercialization opportunities and start companies around them.
Please connect with SVS if you would like to engage with us in our startup and investment efforts.

Return on Research (ROR) Analysis

Commercialization Revenue per Research Dollar

Top Universities by Return on Research (ROR)

ROI Ratio: Commercialization Revenue ÷ Research Funding

University Innovation Analysis

Total Innovation Scores by Institution

Top Universities by Innovation Score

180+ High Innovation
150-179 Strong Innovation
130-149 Moderate Innovation
100-129 Emerging Innovation

130+ total score considered high innovation impact

SVS Innovation Index

Proprietary Assessment of University of North Carolina at Chapel Hill's Innovation Ecosystem
Score out of 100. Benchmark: Top 50 U.S. research institutions.
A score of 90/100 can be read "doing better than 90% of schools benchmarked"

Innovation Visibility

72/100
Definition: Media mentions, publication count, and global research visibility metrics

Startup Momentum

7/100
Definition: Growth in patents, funding, and startup formation

Ecosystem Strength

22/100
Definition: Tech transfer infrastructure and support systems

Innovation Legacy

A Timeline of Groundbreaking Discoveries

Innovation Timeline

Founded
1789
First Nobel
1959
First Patent
1981
First IPO
1993
2022-2024
AI-driven drug discovery
2025
Today

Notable Commercialization Outcomes

Nobel Prizes

8

1984
Nucleic Acid

First gene patent issued

1984
Drug Discovery

Early HIV drug development

1990s
Patent License

Exclusive license for Remdesivir

2001
Biotech Spinout

Launch of Carbylan Therapeutics

2010s
Start-up Launch

Founded Locus Biosciences

2017

Competitive Benchmarking

University of North Carolina at Chapel Hill vs. Peer Research Universities

University of North Carolina at Chapel Hill vs Peers Comparison

Metric University of North Carolina at Chapel Hill (FY2023) Peer Average Elite Average
Annual R&D Expenditure $1,550M $855M $1,675M
New Inventions Disclosed 12 200 400
Startups Formed 6 7 10
Visibility Index 13 12 23
Licensing Revenue $15M $17M $46M
Note: Peer Average = Median value among U.S. R1 research universities. Elite Average = Top 10 ranked U.S. research universities.

Emerging Opportunities

1. AI-Driven Drug Discovery Accelerates Therapeutic Development
UNC’s AI platform rapidly identifies drug candidates, addressing high R&D costs and lengthy timelines in pharmaceuticals, enabling scalable, cost-effective medical breakthroughs.
2. Next-Generation Cancer Immunotherapy with Enhanced Efficacy
Innovative immunotherapy from UNC targets resistant tumors, offering scalable, personalized cancer treatment with competitive advantages in patient outcomes and market demand.
3. Sustainable Bioplastics from Renewable Biomass Feedstocks
UNC’s bioplastic technology reduces plastic pollution by converting biomass into eco-friendly materials, meeting growing environmental regulations and global market scalability.
4. Precision Agriculture Sensors for Optimized Crop Yields
Advanced sensor technology improves farming efficiency, reducing resource waste and increasing yields, scalable across global agriculture markets with strong competitive differentiation.
5. Cybersecurity Solutions Using Quantum-Resistant Algorithms
UNC-developed algorithms protect data against future quantum attacks, addressing critical security needs with scalable applications in finance, defense, and enterprise sectors.
6. Advanced Neural Interfaces for Brain-Machine Communication
Cutting-edge neural interface devices enable seamless brain-computer interaction, revolutionizing medical prosthetics and augmentative tech markets with scalable, high-impact applications.